XBIO - Xenetic Biosciences Inc. Stock Price

Graphic logo of Xenetic Biosciences (XBIO)

Xenetic Biosciences (XBIO) generates revenue through licensing royalties for its PolyXen technology, which extends the efficacy of medications. The business also relies on developing tools to enhance chemotherapy, attracting investment through the protection of intellectual property. The current metric stands at 1.61. The market price action below illustrates the dynamics of the asset developing XCART, a cellular pathway modulation system featuring unique therapeutic protocols.

XBIO - xeneticbio.com Market Chart over the range 07/04/2022 - 11/18/2026

Metric breakdowns and analytics for Xenetic Biosciences (XBIO)

- current price and projected stock value:
Comprehensive company analysis:XBIO xeneticbio.com
Brand item of Xenetic Bio

To select high-quality assets, an investor must evaluate the market value of a business as the discounted expectation of future cash flows. This indicator measures the market's aggregate risk appetite, which for Xenetic Biosciences (XBIO), adhering to strict bio-waste disposal regulations, determines the value of its technological potential, while the linear price chart visualizes the company's current resilience to macroeconomic shocks.

Who Xenetic Biosciences competes with

Price Chart BeiGene Oncology (ONC)|HALO (Halozyme) - Price Performance Chart|RevMed - Stock Quotes|Stock Price Ascentage Pharma Corp AAPG|CGON - Price Chart|Price Rate Chart urogen.com (URGN)|BCAX (Bicara Bio) - Stock Quotes|PSNL (Personalis) - Price Chart|ERAS (Erasca Oncology) - Stock Price|Stock Quotes Delcath (DCTH)|Stock Price YMAB|Stock Price aurabiosciences.com (AURA)|Price Chart candeltx.com CADL|ARAY: Share Price|SELLAS Life Sciences Group Inc. - Stock Price|Actuate Therapeutics, Inc (ACTU) - Stock Quotes|CTOR: Stock Price|Market Price TuHURA (HURA)|Price Chart Protara Therapeutics, Inc.|FATE: Price Performance Chart|Stock Quotes WHWK (Aadi Bioscience, Inc.)|TCRX (TScan Therapeutics, Inc.) - Price Performance Chart|Stock Price CSBR (Champions Oncology)|XBIT - Stock Quotes|CVM - Price Chart|OSTX - Stock Price|Radiopharm Theranostics Limited (RADX) - Price Chart|Artiva Biotherapeutics Inc. - Price Performance Chart|ANL (Adlai Nortye Limited) - Stock Price|Market Price Veru VERU|Stock Quotes TPST (Tempest Therapeutics)|Market Chart Xilio Therapeutics Inc|Stock Price RENB (Renovaro)|Stock Price Mural Oncology plc MURA|Kairos Pharma Limited - Stock Price|OKUR - Stock Price|w2.cytomed.sg (GDTC) - Price Chart|CRIS - Market Chart|Price Chart Apollomics, Inc.|Tharimmune Corporation (THAR) - Market Chart|Stock Price ADVB|GNPX - Market Price|Calidi Biotherapeutics - Stock Quotes|SBFM: Share Price|SLRX - Price Chart|PPBT: Price Chart|AONC (AON) - Stock Quotes|BGNE (BeiGene) - Price Chart|Stock Quotes CKPT|ELEV: Price Performance Chart|Stock Price ICAD|Price Chart IKNA (Ikena Oncology Inc.)|Price Chart notablelabs.com NTBL|Price Performance Chart VIRX|MOR - Price Chart|NAYA (NAYA Biosciences Inc.) - Share Price|AAPGV: Stock Price